The stock has a 36-month beta value of -1.50. Opinions on the stock are mixed, with 3 analysts rating it as a “buy”, 2 as “overweight”, 0 as “hold”, and 0 as “sell”.
On July 04, 2025, the average trading volume of BLTE was 37.28K shares.
BLTE stock’s latest price update
Belite Bio Inc ADR (NASDAQ: BLTE)’s stock price has gone rise by 4.67% in comparison to its previous close of $56.81, however, the company has experienced a -0.73% decrease in its stock price over the last five trading days. globenewswire.com reported 2025-07-02 that – 500 subjects enrolled across the United States, the United Kingdom, France, Czech Republic, Switzerland, China, Taiwan, and Australia
BLTE’s Market Performance
BLTE’s stock has fallen by -0.73% in the past week, with a monthly drop of -8.26% and a quarterly drop of -9.02%. The volatility ratio for the week is 4.24% while the volatility levels for the last 30 days are 3.48% for Belite Bio Inc ADR. The simple moving average for the past 20 days is -0.98% for BLTE’s stock, with a -3.43% simple moving average for the past 200 days.
Analysts’ Opinion of BLTE
Many brokerage firms have already submitted their reports for BLTE stocks, with Maxim Group repeating the rating for BLTE by listing it as a “Buy”. The predicted price for BLTE in the upcoming period, according to Maxim Group is $60 based on the research report published on December 14, 2023 of the previous year 2023.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see BLTE reach a price target of $43. The rating they have provided for BLTE stocks is “Overweight” according to the report published on July 28th, 2023.
H.C. Wainwright gave a rating of “Buy” to BLTE, setting the target price at $58 in the report published on August 01st of the previous year.
BLTE Trading at -3.49% from the 50-Day Moving Average
After a stumble in the market that brought BLTE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.28% of loss for the given period.
Volatility was left at 3.48%, however, over the last 30 days, the volatility rate increased by 4.24%, as shares sank -8.91% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.86% upper at present.
During the last 5 trading sessions, BLTE fell by -0.73%, which changed the moving average for the period of 200-days by +21.80% in comparison to the 20-day moving average, which settled at $60.05. In addition, Belite Bio Inc ADR saw 29.78% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Nathan Mata, the Affiliate of Belite Bio Inc ADR, proposed sale 30,166 shares at $67.80 during a trade that took place back on Mar 19 ’25, which means that Nathan Mata is holding N/A shares at $2,045,126 based on the most recent closing price.
Stock Fundamentals for BLTE
The total capital return value is set at -0.3%. Equity return is now at value -33.43%, with -32.07% for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 24.31.
Conclusion
To sum up, Belite Bio Inc ADR (BLTE) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
